Irving, Texas — According to state and local economic development sources NEXT Oncology plans to invest $1,365,000.00 to build out 12,200 square feet of new space in Irving. The company plans to occupy the new space at 6750 North MacArthur Blvd., Suite 250 in Irving, on or about November 1, 2022. According to the company website NEXT Oncology, founded by Anthony W. Tolcher, M. D. , FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolchers passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough. Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers. This is not a job for Dr. Tolcher, it is his passion.

To learn more about NEXT Oncology, visit http://nextoncology.com/

Company Contact:
Anthony Tolcher, Chief Executive Officer
atolcher@nextoncology.com
https://www.linkedin.com/in/anthonytolcher/
210-580-9500

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved